Assessment of the kappa opioid agonist, salvinorin A, as a punisher of drug self-administration in monkeys

Psychopharmacology

Volumn 231, Issue 14, 2014, Pages 2751-2758

  Freeman, Kevin B ^a   Naylor, Jennifer E ^a   Prisinzano, Thomas E ^b   Woolverton, William L ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS   (United States)

Author keywords

Cocaine; Kappa agonist; Monkey; Punishment; Remifentanil; Salvinorin A; Self administration

Indexed keywords

COCAINE; REMIFENTANIL; SALVINORIN A; CLERODANE DERIVATIVE; KAPPA OPIATE RECEPTOR; NARCOTIC ANALGESIC AGENT; PIPERIDINE DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DEPENDENCE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MECHANISM; HAPLORHINI; INSTRUMENTAL CONDITIONING; INTRAVENOUS DRUG ABUSE; MALE; NONHUMAN; PRIORITY JOURNAL; PUNISHMENT; REINFORCEMENT; AGONISTS; ANIMAL; DECISION MAKING; DRUG EFFECTS; DRUG SELF ADMINISTRATION; RHESUS MONKEY;

ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; CHOICE BEHAVIOR; COCAINE; CONDITIONING, OPERANT; DITERPENES, CLERODANE; MACACA MULATTA; MALE; PIPERIDINES; PUNISHMENT; RECEPTORS, OPIOID, KAPPA; SELF ADMINISTRATION;

EID: 84903627776     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3436-2     Document Type: Article

References (36)

1. Azrin NH, Holz WC (1966) Punishment. In: Honig WK (ed) Operant behavior: areas of research and application. Prentice-Hall, Englewood Cliffs, pp 380-447
2. Banks ML, Negus SS (2012) Preclinical determinants of drug choice under concurrent schedules of drug self-administration. Adv Pharmacol Sci 2012:1-7
3. Butelman ER, Mandau M, Tidgewell K, Prisinzano TE, Yuferov V, Kreek MJ (2007) Effects of salvinorin A, a kappa opioid hallucinogen, on a neuroendocrine biomarker assay in nonhuman primates with high kappa receptor homology in humans. J Pharmacol Exp Ther 320:300-306
4. Carlezon WA Jr, Be Guin C, DiNieri JA, Baumann MH, Richards MR, Todtenkopf MS, Rothman RB, Ma Z, Lee DY, Cohen BM (2006) Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. J Pharmacol Exp Ther 316:440-447
5. Chefer VI, Backman CM, Gigante ED, Shippenberg TS (2013) Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion. Neuropsychopharmacology 38(13):2623-2631
6. Cosgrove KP, Carroll ME (2004) Differential effects of bremazocine on oral phencyclidine (PCP) self-administration in male and female rhesus monkeys. Exp Clin Psychopharmacol 12:111-117
7. Cunningham CW, Rothman RB, Prisinzano TE (2011) Neuropharmacology of the naturally occurring k-opioid hallucinogen salvinorin A. Pharmacol Rev 63:316-347
8. Czoty PW, Nader MA (2012) Individual differences in the effects of environmental stimuli on cocaine choice in socially housed male cynomogus monkeys. Psychopharm 224:69-79
9. Deroche-Gamonet V, Belin D, Piazza PV (2004) Evidence for addiction-like behavior in the rat. Science 305:1014-1017
10. Ebner SR, Roitman MF, Potter DN, Rachlin AB, Chartoff EH (2010) Depressive-like effects of the kappa opioid receptor agonist salvinorin A are associated with decreased phasic dopamine release in the nucleus accumbens. Psychopharm 210:241-252
11. Freeman KB, McMaster BM, Roma PG, Woolverton WL (2014) Punishment with histamine reduces the reinforcing effectiveness of cocaine in monkeys. Psychopharm, in Press
12. Glick SD, Maisonneuve IM, Raucci J, Archer S (1995) Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Res 681:147-152
13. Goldberg SR (1980) Histamine as a punisher in squirrel monkeys: effects of pentobarbital, chlordiazepoxide, and H1- and H2-receptor antagonists on behavior and cardiovascular responses. J Pharmacol Exp Ther 214:726-736
14. Grove RN, Schuster CR (1974) Suppression of cocaine self-administration by extinction and punishment. Pharmacol Biochem Behav 2:199-208
15. Holtz NA, Anker JJ, Reiger PS, Claxton A, Carroll ME (2013) Cocaine self-administration punished by i.v. histamine in rat models of high and low drug abuse vulnerability: effects of saccharin preference, impulsivity, and sex. Physiol Behav 122:32-38
16. Iglauer C, Woods JH (1974) Concurrent performances: reinforcement by different doses of intravenous cocaine in rhesus monkeys. J Exp Anal Behav 22:179-196
17. Johanson CE (1977) The effects of electric shock on responding maintained by cocaine in a choice procedure in the rhesus monkey. Psychopharm 53:277-282
18. Johanson CE, Schuster CR (1975) A choice procedure for drug reinforcers: cocaine and methylphenidate in the rhesus monkey. J Pharmacol Exp Ther 193:676-688
19. Katz JL, Goldberg SR (1986) Effects of H1-receptor antagonists on responding punished by histamine injection or electric shock presentation in squirrel monkeys. Psychopharm 90:461-467
20. Maisonneuve IM, Archer S, Glick SD (1994) U50488, a k-opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats. Neurosci Lett 181:57-60
21. Mello NK, Negus SS (1998) Effects of kappa opioid agonists on cocaine- and food-maintained responding by rhesus monkeys. J Pharmacol Exp Ther 286:812-824
22. Mello NK, Negus SS (2000) Interactions between kappa opioid agonists and cocaine. Preclinical studies. Ann N Y Acad Sci 909:104-132
23. Morani AS, Kivell B, Prisinzano TE, Schenk S (2009) Effect of kappa-opioid receptor agonists U69,593, U50488H, spiradoline and salvinorin A on cocaine-induced drug-seeking in rats. Pharmacol Biochem Behav 94:244-249
24. Negus SS (2005) Effects of punishment on choice between cocaine and food in rhesus monkeys. Psychopharm 181:244-252
25. Negus SS (2006) Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone. J Pharmacol Exp Ther 317:711-723
26. Negus SS, Mello NK, Portoghese PS, Lin CE (1997) Effects of kappa opioids on cocaine self-administration by rhesus monkeys. J Pharmacol Exp Ther 278:1282-1289
27. Negus SS, Schrode K, Stevenson GW (2007) Mu/Kappa opioid interactions in rhesus monkeys: implications for analgesia and abuse liability. Exp Clin Psychopharm 16:386-399
28. Pfeiffer A, Brantl V, Herz A, Emrich HM (1986) Psychotomimesis mediated by kappa opiate receptors. Science 233:774-776
29. Podlesnik CA, Jimez-Gomez C, Woods JH (2010) A choice procedure to assess the aversive effects of drugs in rodents. J Exp Anal Behav 93:203-223
30. Prisinzano TE, Tidgewell K, Harding WW (2005) k Opioids as potential treatments for stimulant dependence. AAPS J 7:E592-E599
31. Ruedi-Bettschen D, Rowlett JK, Spealman RD, Platt DM (2010) Attenuation of cocaine-induced reinstatement of drug seeking in squirrel monkeys: kappa opioid and serotonergic mechanisms. Psychopharm 210:169-177
32. Schenk S, Partridge B, Shippenberg TS (1999) U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking. Psychopharm 144:339-346
33. Woolverton WL (2003) A novel method for studying drugs as punishers. Pharmacol Biochem Behav 76:125-131
34. Woolverton WL, Freeman KB, Myerson J, Green L (2012) Suppression of cocaine self-administration in monkeys: effects of delayed punishment. Psychopharm 220:509-517
35. Zhang Y, Butelman ER, Schlussman SD, Ho A, Kreek MJ (2004) Effect of the kappa opioid agonist R-84760 on cocaine-induced increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6 J mice. Psychopharm 173:146-152
36. Zhang Y, Butelman ER, Schlussman SD, Ho A, Kreek MJ (2005) Effects of the plant-derived hallcuinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors. Psychopharm 179:551-558